Sign in
Join
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Search
Type here...
Search
Home
Trending
Analysis
Research Reports
Contact Us
START FREE TRAIL
My account
Get into your account.
Login
Register
Search
Type here...
Search
Home
Trending
Analysis
Research Reports
Contact Us
START FREE TRAIL
My account
Get into your account.
Login
Register
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Home
About Us
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Home
About Us
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Tag:
Healthcare
Healthcare
Technology & AI
Healthcare
M&A
Consumer & Retail
Energy
Pfizer Takes On Eli Lilly & Novo: Who Gets OUTPLAYED in the Obesity Arms Race?
Healthcare
Ishan Majumdar
-
February 4, 2026
Pfizer just released mid-stage data from its Metsera-acquired obesity drug showing 12.3% weight loss at 28 weeks with monthly...
UnitedHealth CRASHES After Shocking Medicare Ruling — The Fallout Explained!
Healthcare
Ishan Majumdar
-
February 1, 2026
When a 0.09% number sends $96 billion out the window, you know something serious just happened. On January 27,...
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...
Boston Scientific Penumbra Acquisition: The $15 Billion Gamble That Could Dominate Neurovascular Markets
Healthcare
Ishan Majumdar
-
January 16, 2026
If you're wondering what Boston Scientific (NYSE:BSX) has been up to lately, buckle up. On January 15, the medtech...
AbbVie Trump Investment Deal: How Medicaid Cuts Bought Regulatory Peace!
Healthcare
Ishan Majumdar
-
January 13, 2026
AbbVie (NYSE:ABBV) just made a bold move—and the stakes are massive. The company agreed to invest $100 billion into...
Merck Revolution Medicines Acquisition: The $30 Billion Pipeline Gamble That Could Pay Off
Healthcare
Ishan Majumdar
-
January 10, 2026
Merck (NYSE:MRK) is making headlines again, this time for reportedly circling Revolution Medicines (NASDAQ:RVMD) in what could be one...
Niagen NR Patent Acquisition Unlocks Massive Pharma Potential—But There’s a Catch!
Healthcare
Ishan Majumdar
-
December 26, 2025
If you blinked, you may have missed one of the more intriguing biotech moves of the year. Niagen Bioscience...
BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination
Healthcare
Ishan Majumdar
-
December 23, 2025
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...
Eli Lilly Adverum Acquisition Could Reshape Gene Therapy!
Healthcare
Ishan Majumdar
-
December 19, 2025
Eli Lilly (NYSE:LLY) isn’t slowing down. After a quarter filled with blockbuster drug launches, accelerated global uptake of Mounjaro...
Mirum Bluejay Acquisition Unlocks Rare Disease Gold!
Healthcare
Ishan M.
-
December 19, 2025
Mirum Pharmaceuticals (NASDAQ:MIRM) is making big moves. In early December 2025, the company announced its plan to acquire privately...
Novartis Gene Therapy Approval: A New Multi-Billion Dollar Market?
Healthcare
Ishan M.
-
December 19, 2025
Novartis just scored a big win with a major Novartis gene therapy approval —and it could reshape the gene...
Abbott Exact Sciences Acquisition: $21B Cancer Gamble
M&A
Ishan Majumdar
-
December 19, 2025
Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...
Load more
Pfizer Takes On Eli Lilly & Novo: Who Gets OUTPLAYED in the Obesity Arms Race?
Healthcare
Ishan Majumdar
-
February 4, 2026
Pfizer just released mid-stage data from its Metsera-acquired obesity drug showing 12.3% weight loss at 28 weeks with monthly...
UnitedHealth CRASHES After Shocking Medicare Ruling — The Fallout Explained!
Healthcare
Ishan Majumdar
-
January 28, 2026
When a 0.09% number sends $96 billion out the window, you know something serious just happened. On January 27,...
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech circles after its shares surged 7.5%...
Boston Scientific Penumbra Acquisition: The $15 Billion Gamble That Could Dominate Neurovascular Markets
Healthcare
Ishan Majumdar
-
January 16, 2026
If you're wondering what Boston Scientific (NYSE:BSX) has been up to lately, buckle up. On January 15, the medtech...
AbbVie Trump Investment Deal: How Medicaid Cuts Bought Regulatory Peace!
Healthcare
Ishan Majumdar
-
January 13, 2026
AbbVie (NYSE:ABBV) just made a bold move—and the stakes are massive. The company agreed to invest $100 billion into...
Merck Revolution Medicines Acquisition: The $30 Billion Pipeline Gamble That Could Pay Off
Healthcare
Ishan Majumdar
-
January 10, 2026
Merck (NYSE:MRK) is making headlines again, this time for reportedly circling Revolution Medicines (NASDAQ:RVMD) in what could be one...
Niagen NR Patent Acquisition Unlocks Massive Pharma Potential—But There’s a Catch!
Healthcare
Ishan Majumdar
-
December 23, 2025
If you blinked, you may have missed one of the more intriguing biotech moves of the year. Niagen Bioscience...
BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination
Healthcare
Ishan Majumdar
-
December 20, 2025
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion all-cash acquisition of Amicus Therapeutics. The...
Eli Lilly Adverum Acquisition Could Reshape Gene Therapy!
Healthcare
Ishan Majumdar
-
December 10, 2025
Eli Lilly (NYSE:LLY) isn’t slowing down. After a quarter filled with blockbuster drug launches, accelerated global uptake of Mounjaro...
Mirum Bluejay Acquisition Unlocks Rare Disease Gold!
Healthcare
Ishan M.
-
December 9, 2025
Mirum Pharmaceuticals (NASDAQ:MIRM) is making big moves. In early December 2025, the company announced its plan to acquire privately...
Novartis Gene Therapy Approval: A New Multi-Billion Dollar Market?
Healthcare
Ishan M.
-
November 26, 2025
Novartis just scored a big win with a major Novartis gene therapy approval —and it could reshape the gene...
Abbott Exact Sciences Acquisition: $21B Cancer Gamble
M&A
Ishan Majumdar
-
November 21, 2025
Abbott Laboratories is back in the M&A spotlight. Just days after confirming its plan to buy cancer-screening heavyweight Exact...